Table 2.
Frequently reported AEs (>5% in either group)
C.E.R.A., n = 150 (%) | Darbepoetin alfa, n = 155 (%) | |
Hypertension | 24 (16.0) | 37 (23.9) |
Renal impairment | 9 (6.0) | 16 (10.3) |
Hyperkalaemia | 13 (8.7) | 8 (5.2) |
Upper respiratory tract infection | 9 (6.0) | 11 (7.1) |
Constipation | 5 (3.3) | 12 (7.7) |
Diarrhoea | 10 (6.7) | 6 (3.9) |
Urinary tract infection | 6 (4.0) | 8 (5.2) |
Hypotension | 5 (3.3) | 8 (5.2) |
Nasopharyngitis | 5 (3.3) | 8 (5.2) |
Pneumonia | 2 (1.3) | 8 (5.2) |